1006 related articles for article (PubMed ID: 18291018)
21. Treatment of patients with high risk localized prostate cancer: results from cancer of the prostate strategic urological research endeavor (CaPSURE).
Meng MV; Elkin EP; Latini DM; Duchane J; Carroll PR
J Urol; 2005 May; 173(5):1557-61. PubMed ID: 15821485
[TBL] [Abstract][Full Text] [Related]
22. Partnership and outcomes in men with prostate cancer.
Bergman J; Gore JL; Saigal CS; Kwan L; Litwin MS
Cancer; 2009 Oct; 115(20):4688-94. PubMed ID: 19626653
[TBL] [Abstract][Full Text] [Related]
23. Cross-sectional and longitudinal comparisons of health-related quality of life between patients with prostate carcinoma and matched controls.
Hoffman RM; Gilliland FD; Penson DF; Stone SN; Hunt WC; Potosky AL
Cancer; 2004 Nov; 101(9):2011-9. PubMed ID: 15452835
[TBL] [Abstract][Full Text] [Related]
24. Bowel function and bother after treatment for early stage prostate cancer: a longitudinal quality of life analysis from CaPSURE.
Litwin MS; Sadetsky N; Pasta DJ; Lubeck DP
J Urol; 2004 Aug; 172(2):515-9. PubMed ID: 15247718
[TBL] [Abstract][Full Text] [Related]
25. Quality of life in men with locally advanced adenocarcinoma of the prostate: an exploratory analysis using data from the CaPSURE database.
White WM; Sadetsky N; Waters WB; Carroll PR; Litwin MS
J Urol; 2008 Dec; 180(6):2409-13; discussion 2414. PubMed ID: 18930270
[TBL] [Abstract][Full Text] [Related]
26. Prostate brachytherapy: a descriptive analysis from CaPSURE.
Lee WR; Sharkey J; Cowan JE; DuChane J; Carroll PR;
Brachytherapy; 2007; 6(2):123-8. PubMed ID: 17434105
[TBL] [Abstract][Full Text] [Related]
27. What percentage of patients with newly diagnosed carcinoma of the prostate are candidates for surveillance? An analysis of the CaPSURE database.
Barocas DA; Cowan JE; Smith JA; Carroll PR;
J Urol; 2008 Oct; 180(4):1330-4; discussion 1334-5. PubMed ID: 18707731
[TBL] [Abstract][Full Text] [Related]
28. Sociodemographic and clinical risk characteristics of patients with prostate cancer within the Veterans Affairs health care system: data from CaPSURE.
Cooperberg M; Lubeck DP; Penson D; Mehta SS; Carroll PR; Kane CJ
J Urol; 2003 Sep; 170(3):905-8. PubMed ID: 12913727
[TBL] [Abstract][Full Text] [Related]
29. Fear of cancer recurrence in patients undergoing definitive treatment for prostate cancer: results from CaPSURE.
Mehta SS; Lubeck D; Pasta DJ; Litwin MS
J Urol; 2003 Nov; 170(5):1931-3. PubMed ID: 14532810
[TBL] [Abstract][Full Text] [Related]
30. Health-related quality of life, satisfaction, and economic outcome measures in studies of prostate cancer screening and treatment, 1990-2000.
McNaughton-Collins M; Walker-Corkery E; Barry MJ
J Natl Cancer Inst Monogr; 2004; (33):78-101. PubMed ID: 15504921
[TBL] [Abstract][Full Text] [Related]
31. Who is the average patient presenting with prostate cancer?
Greene KL; Cowan JE; Cooperberg MR; Meng MV; DuChane J; Carroll PR;
Urology; 2005 Nov; 66(5 Suppl):76-82. PubMed ID: 16194711
[TBL] [Abstract][Full Text] [Related]
32. Changes in quality of life among low-income men treated for prostate cancer.
Brar R; Maliski SL; Kwan L; Krupski TL; Litwin MS
Urology; 2005 Aug; 66(2):344-9. PubMed ID: 16040094
[TBL] [Abstract][Full Text] [Related]
33. The contemporary management of prostate cancer in the United States: lessons from the cancer of the prostate strategic urologic research endeavor (CapSURE), a national disease registry.
Cooperberg MR; Broering JM; Litwin MS; Lubeck DP; Mehta SS; Henning JM; Carroll PR;
J Urol; 2004 Apr; 171(4):1393-401. PubMed ID: 15017184
[TBL] [Abstract][Full Text] [Related]
34. Quality of life for men receiving a second treatment for prostate cancer.
Arredondo SA; Latini DM; Sadetsky N; Kawakami J; Pasta DJ; DuChane J; Carroll PR;
J Urol; 2007 Jan; 177(1):273-8; discussion 278-9. PubMed ID: 17162062
[TBL] [Abstract][Full Text] [Related]
35. Regret in men treated for localized prostate cancer.
Hu JC; Kwan L; Saigal CS; Litwin MS
J Urol; 2003 Jun; 169(6):2279-83. PubMed ID: 12771770
[TBL] [Abstract][Full Text] [Related]
36. Reduced incidence of bony metastasis at initial prostate cancer diagnosis: data from CaPSURE.
Ryan CJ; Elkin EP; Small EJ; Duchane J; Carroll P
Urol Oncol; 2006; 24(5):396-402. PubMed ID: 16962488
[TBL] [Abstract][Full Text] [Related]
37. Coping and health-related quality of life in men with prostate cancer randomly assigned to hormonal medication or close monitoring.
Green HJ; Pakenham KI; Headley BC; Gardiner RA
Psychooncology; 2002; 11(5):401-14. PubMed ID: 12228873
[TBL] [Abstract][Full Text] [Related]
38. Quality-of-life outcomes for men with prostate carcinoma detected by screening.
Smith DS; Carvalhal GF; Schneider K; Krygiel J; Yan Y; Catalona WJ
Cancer; 2000 Mar; 88(6):1454-63. PubMed ID: 10717630
[TBL] [Abstract][Full Text] [Related]
39. Treatment failure after primary and salvage therapy for prostate cancer: likelihood, patterns of care, and outcomes.
Agarwal PK; Sadetsky N; Konety BR; Resnick MI; Carroll PR;
Cancer; 2008 Jan; 112(2):307-14. PubMed ID: 18050294
[TBL] [Abstract][Full Text] [Related]
40. Impact of salvage therapy for biochemical recurrence on health-related quality of life following radical prostatectomy.
Namiki S; Saito S; Tochigi T; Ioritani N; Terai A; Arai Y
Int J Urol; 2007 Mar; 14(3):186-91. PubMed ID: 17430252
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
